
38 episodes

DTx Podcast with Eugene Borukhovich Digital Health Today
-
- Health & Fitness
-
-
5.0 • 9 Ratings
-
Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.
-
Gamifying Healthcare to Enable Behavior Change: Pamela Stahl Shares Insights into Sidekick Heath's Digital Therapeutics
In this episode we jumped right into the drug+ discussion with Pamela Stahl, Chief Commercial Officer at Sidekick Health.
In their own words Sidekick health is all about “Gamified digital therapeutics built on science, rooted in behavioral economics, and scalable across multiple therapeutic areas.”
In this episode, we cover:
The origin of Sidekick Health and what led Tryggvi to start the company
The funding journey from being a young company in Iceland to today
Patient and health consumer experience
Combining clinical evidence with gamification
The complexities of clinical trials with pharma clients
And much more!
Guest Links and Resources:
Connect with Pamela Stahl on LinkedIn
Visit sidekickhealth.com
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram -
Diagnosing Autism Spectrum Disorder with DTx: Dennis Wall provides insights into Canvas Dx
In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa.
In their owns words, “Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.”
In this episode, we cover:
The founding story and funding journey of Cognoa
Patient journey for children using Canvas Dx for autism spectrum disorder (ASD) diagnostic and therapeutics
How the diagnosis and treatment interplay works in the context of a autism digital therapeutic
Evidence generation journey
Working flexibly with pediatricians and doctors for distribution
The collaborative care model alongside DTx
Guest Links and Resources:
Connect with Dennis Wall on LinkedIn | Twitter
Visit: cognoa.com
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram -
Investing in Digital Health: Justin Norden Shares Insights Into Succeeding in DTx
In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.
Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.
In this episode, we cover:
The Healthcare Thesis at GSR Ventures
Virtual Reality (VR) Digital Therapeutics
Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx
What it would take to scale existing Prescription Digital Therapeutics
The Role Of Health Coaching alongside AI automation
The Drivers of Success Going Forward for the Digital Therapeutics Market
Guest Links and Resources:
Connect with Justin Norden on LinkedIn | Twitter
Visit https://gsrventuresglobal.com
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram -
DTx for GI Disorders and Migraine: How Can Gut Directed Hypnotherapy Make a Positive Impact for Patients?
Gut-directed hypnotherapy has an ability to retrain both nervous systems to work together to communicate better, giving the central nervous system the ability to downregulate the hyper vigilant signals that are being sent up from the enteric nervous system.
Despite there being over 20 different randomized controlled trials showing that gut directed hypnotherapy has a positive impact on all of the symptoms of for functional GI disorders, experts still don't really know exactly why it works
To learn more about the future of gut-directed hypnotherapy and the role DTx can play, I went straight to Tim Rudolphi, CEO of metaMe Health.
metaMe, in their own words “believe the best medicine may not be medicine at all. By developing innovative prescription digital therapeutics (PDTs) to combat many common chronic conditions, they are putting the power to heal right in the hands of their patients.” starting with gut health.
In this episode, we cover:
The founding story of metaMe Health
The scientific thesis behind gut-directed hypnotherapy
metaMe’s business hypothesis in action: the process of selling prescription digital therapeutic to a doctor
Commercialization of Prescription Digital Therapeutics
Making space for DTx alongside health coaching
Guest Links and Resources:
Connect with Tim Rudolphi on LinkedIn | Twitter
Visit: metamehealth.com
Episode Mentions:
Danny Bern
Brian Dolan
The Lancet
Mahana
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram -
Data Driven Healthcare Services: Kuldeep Singh Rajput Shares Insights on Evolving DTx into Virtual Care Platforms
Biofourmis is not your typical standalone DTx company! On the heels of a $300M round, Biofourmis has evolved to a full data driven healthcare services organization with a strong foundation of digital therapies driving care decisions.
To learn more about their work and plans for the future, I went straight to Kuldeep Singh Rajput, founder and CEO of Biofourmis.
Biofourmis, in their own words, “utilizes machine learning, integrated technology and an FDA-cleared analytics engine to streamline connections between patients and care teams, leading to better outcomes for all.”
In this episode we cover:
The path from creation to funding
Digital therapeutic companies evolving into virtual care platforms
Kuldeep’s business hypothesis to entrepreneurial journey
Being device agnostic: build vs buy
Patient adoption and utilization
And much more!
Guest Links and Resources:
Connect with Kuldeep Singh on LinkedIn | Twitter
Visit biofourmis.com
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram -
Treating Disease Progression with DTx: Dr. Mark Berman Shares Insights on Innovative Prescription Digital Therapeutics
Cognitive behavioral therapy (CBT) is an evidence-based form of therapy that has been in use for decades. My guest in this episode believes that CBT can be applied to create better therapeutics, and, in fact, that's exactly what his company is called: Better Therapeutics.
Dr. Mark Berman, the Chief Medical Officer at Better Therapeutics, explained that the goal of CBT is to "help people change some of those core beliefs, which then directly influence what we do on a day to day basis."
And while CBT was originally applied to help people with conditions like PTSD, anxiety and depression, the team at Better Therapeutics have developed their own variant of CBT to apply the core principles of CBT to the ideas that drive root behaviors like diet, exercise and other supportive lifestyle behaviors.
Tune into this episode to hear how Better Therapeutics are creating new digital treatments to reverse the progression of cardiometabolic disease, improve quality of life and inform clinical decisions.
In this episode, we cover:
Patient experience using digital therapeutics for type 2 diabetes
Nutritional CBT - Better Therapeutics innovative new form of Cognitive Behavioral Therapy
Why companies are opting to create Prescription Digital Therapies rather than self-managed lifestyle apps
What’s next in the Better Therapeutics pipeline and how these decisions are made
The future of Digital Therapeutic infrastructure
Guest Links and Resources:
Connect with Mark Berman on LinkedIn | Twitter
Visit bettertx.com
Episode Mentions:
Kevin Appelbaum - founder of Better TX: LinkedIn
Margaret Moore - Founder & CEO Wellcoaches Corporation: LinkedIn
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Customer Reviews
Loved every episode
Very informative and a must for digital health entrepreneurs
The real deal
Eugene brings out the real digital health stories from those who have lived them. A great listen.
Amazing content!
I love the selection of guests, great stories and deep dives into the strategies of my favorite companies.